Home/Publication/HongShan, FreeS Fund Double Down on Biomanufacturing Tech
HongShan, FreeS Fund Double Down on Biomanufacturing Tech 

02 Aug 2024

US$ 19.00

Hongshan, FreeS Fund and CDH Venture and Growth Capital were party to the over Rmb150 million (US$20.8 million) ......

Price / article: US$19.00
OR existing subscriber
Related Publications

Creaegis has led the US$45 million Series B funding round for subscription-based employee healthcare provider Onsurity...

The Longreach Group (Longreach) announced the final closing of Longreach Capital Partners 4 (Longreach 4) at ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.